Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Skillbäck

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Alzheimer'S Research & Therapy|February 1, 2014
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesTobias Skillbäck, Henrik Zetterberg, Kaj Blennow, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 21, 2017
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survivalTobias Skillbäck, Niklas Mattsson, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2019
Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's DiseaseTobias Skillbäck, Johannes Kornhuber, Kaj Blennow, et al.
European Journal of Clinical Investigation|February 7, 2019
Peptidomic analysis of cartilage and subchondral bone in OA patientsBirgitta Gatenholm, Johan Gobom, Tobias Skillbäck, et al.
JAMA Neurology|February 26, 2014
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality RegistryTobias Skillbäck, Christoffer Rosén, Fredrik Asztely, et al.
AIDS Research and Therapy|July 16, 2015
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's diseaseSignar Mäkitalo, Åsa Mellgren, Ellen Borgh, et al.
Advances in Clinical Chemistry|September 20, 2014
CSF in Alzheimer's diseaseHenrik Zetterberg, Ronald Lautner, Tobias Skillbäck, et al.
Biomarkers in Medicine|August 25, 2012
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challengesJonathan W Bartlett, Chris Frost, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsKelly Rombauts, Johan Skoog, Tobias Skillbäck, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal FluidKarl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Alzheimer'S Research & Therapy|February 1, 2014
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesTobias Skillbäck, Henrik Zetterberg, Kaj Blennow, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 21, 2017
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survivalTobias Skillbäck, Niklas Mattsson, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|May 20, 2019
Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's DiseaseTobias Skillbäck, Johannes Kornhuber, Kaj Blennow, et al.
European Journal of Clinical Investigation|February 7, 2019
Peptidomic analysis of cartilage and subchondral bone in OA patientsBirgitta Gatenholm, Johan Gobom, Tobias Skillbäck, et al.
JAMA Neurology|February 26, 2014
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality RegistryTobias Skillbäck, Christoffer Rosén, Fredrik Asztely, et al.
AIDS Research and Therapy|July 16, 2015
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's diseaseSignar Mäkitalo, Åsa Mellgren, Ellen Borgh, et al.
Advances in Clinical Chemistry|September 20, 2014
CSF in Alzheimer's diseaseHenrik Zetterberg, Ronald Lautner, Tobias Skillbäck, et al.
Biomarkers in Medicine|August 25, 2012
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challengesJonathan W Bartlett, Chris Frost, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsKelly Rombauts, Johan Skoog, Tobias Skillbäck, et al.
Journal of Visualized Experiments : Jove|December 30, 2017
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal FluidKarl T Hansson, Tobias Skillbäck, Elin Pernevik, et al.
Pageof 4